Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate Effect on Cytokines in Adult Atopic Dermatitis
NCT03327116Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Nov 2017
- Primary completion
- Jul 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of methotrexate in atopic dermatitis (AD), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoint: Change from baseline of cytokines and chemokines expression at 24 weeks. Started Nov 2017; status: completed.
02
Drugs
methotrexate
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03327116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03327116.